The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

DLA Piper LLP (US)

Andrew Escobar

Tel:
Work 1 206 839 4828
Email:
DLA Piper LLP (US)

Work Department

Litigation Securities

Position

Partner

Career

Andrew Escobar's practice focuses on securities, complex commercial, class action and real estate litigation.

 

He is admitted to practice in Washington, California, Oregon, and New York and regularly defends cases in all four jurisdictions.

Education

JD, Yale Law School; BA, University of Southern California


United States: Dispute resolution

Securities litigation: defense

Within: Securities litigation: defense

John Clarke in New York and James Mathias in Baltimore are chairs of DLA Piper LLP (US)’s corporate and securities litigation practice, which continued to expand its roster of talent in 2017. Recent hires include Jessica Masella in New York, who was a member of the securities and commodities fraud task force in the Criminal Division of the US Attorney's Office for the Southern District of New York, and experienced trial lawyer Amy Rudd in Austin, who joined from Dechert LLP. They complement the firm’s already strong bench, which includes San Diego-based Shirli Weiss, who won a motion to dismiss for Super Micro Computer in a class action regarding errors in reported revenues, and Robert Brownlie; and Andrew Escobar in Seattle, who with Clarke defended Morgan Stanley against allegations of misstatements and omissions in registration statements for IPOs of SandRidge Mississippian Trusts. Ryan O’Quinn in Miami has in-house experience at the SEC and advises clients in the financial services, healthcare and transportation sectors.

[back to top]


Back to index

Legal Developments by:
DLA Piper LLP (US)

  • Sentencing guidelines for corporate manslaughter

    In February 2010 the Sentencing Guidelines Council (the SGC) issued definitive guidelines to courts on imposing appropriate sentences for corporate manslaughter and health and safety offences causing death. The SGC states that fines imposed on companies found guilty of corporate manslaughter should not fall below £500,000, while fines in respect of health and safety offences that are a significant cause of death should be at least £100,000. Crucially, the SGC declined to provide for a fixed link between the imposed fine and the turnover or profitability of the offending company.

    - DLA Piper UK LLP

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to